I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 7 studies | 28% ± 12% | |
| classical monocyte | 6 studies | 21% ± 6% | |
| conventional dendritic cell | 6 studies | 32% ± 12% | |
| plasmacytoid dendritic cell | 6 studies | 23% ± 6% | |
| fibroblast | 5 studies | 26% ± 10% | |
| natural killer cell | 5 studies | 20% ± 4% | |
| endothelial cell | 5 studies | 25% ± 10% | |
| non-classical monocyte | 4 studies | 19% ± 3% | |
| myeloid cell | 4 studies | 19% ± 5% | |
| epithelial cell | 4 studies | 41% ± 8% | |
| myofibroblast cell | 4 studies | 18% ± 2% | |
| ciliated cell | 4 studies | 22% ± 3% | |
| dendritic cell | 4 studies | 35% ± 5% | |
| regulatory T cell | 4 studies | 19% ± 3% | |
| oligodendrocyte precursor cell | 4 studies | 22% ± 7% | |
| pancreatic A cell | 3 studies | 39% ± 17% | |
| type B pancreatic cell | 3 studies | 37% ± 19% | |
| hematopoietic precursor cell | 3 studies | 23% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| B cell | 3 studies | 19% ± 4% | |
| GABAergic neuron | 3 studies | 36% ± 8% | |
| glutamatergic neuron | 3 studies | 41% ± 11% | |
| connective tissue cell | 3 studies | 23% ± 5% |
